about
Clinical asthma phenotypes in the real world: opportunities and challengesNew combination treatments in the management of asthma: focus on fluticasone/vilanterolBarriers to inhaled gene therapy of obstructive lung diseases: A reviewMetabolomics analysis identifies different metabotypes of asthma severity.Acupuncture for asthma: Protocol for a systematic reviewEditorial inhaled corticosteroids: the endocrine and metabolic complications.Inhaled corticosteroids and bone healthA novel nanobody specific for respiratory surfactant protein A has potential for lung targeting.Comparative effectiveness of inhaled corticosteroids for paediatric asthma: protocol for a systematic review and Bayesian network meta-analysis.Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice.The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma.Inhaled corticosteroids for chronic obstructive pulmonary disease.Inhaled corticosteroids for asthma: on-demand or continuous use.Pharmacotherapy of critical asthma syndrome: current and emerging therapies.Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.The acute management of asthma.A review of standard pharmacological therapy for adult asthma – Steps 1 to 5.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Benefits and Risks of Long-Term Asthma Management in Children: Where Are We Heading?Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.New perspectives in nanotherapeutics for chronic respiratory diseases.A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor.The influence of inhaled corticosteroid discontinuation in children with well-controlled asthma.Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre.Epac Function and cAMP Scaffolds in the Heart and Lung.Establishment of different experimental asthma models in mice.Molecular changes during TGFβ-mediated lung fibroblast-myofibroblast differentiation: implication for glucocorticoid resistance.
P2860
Q26775236-EE59EF0E-C531-4D2B-854F-05B443EAEBABQ26852898-FC609BD4-EA12-4F65-85F4-573CF6CA583EQ29248141-48020AC8-2437-4426-83AA-02516182E294Q33587291-8447DA13-9F8D-4A99-A491-F2D46516682EQ33879735-9D7CBA6D-D0A5-4684-BD9F-3BA0AF533E33Q35056139-46E790FE-0CD1-4762-A421-27E22208643DQ35056142-C312BC34-3B81-43E2-814A-14ED34EEC403Q35491484-1E2AECC7-D5E1-4F08-B91D-984D752F3325Q36205132-94DE8753-62AB-4327-A417-FB281C39E099Q36390211-7963D1A1-AA84-4D27-9E42-C9A4925826BAQ37686313-BCD8DBAE-63FE-434A-8FA2-AD573B308952Q37711220-5E25618C-85BC-4849-A0F1-372CCCC3B59BQ38153757-0427F5C3-2FBD-4B35-9D22-80F08D5904B4Q38154624-6C298448-F161-4D1A-AFE4-54606F51AD57Q38157770-7AFF1FD9-FE5B-4E28-B008-2ECD39CEFE1EQ38198574-462AA664-CB00-486B-95DF-A57B75ADD07BQ38248502-01D8AA72-CF67-42E7-B80F-F7B5603CD103Q38364832-7D9EC7B2-1BF2-4901-AA46-801A32ADEC95Q38571581-55D26686-2099-45D0-885C-6B02F57FAC1AQ38707759-8F1E539C-7729-4FD5-8CF1-4DA94DC3DE48Q38785897-4E508705-BAAB-446E-83CB-0E6BD09F231CQ38851423-BD749DD4-EA59-4114-9FC4-6C787B140D3AQ40039105-358F904A-60ED-40D2-9394-CD7785F9809DQ41287485-D22ECBD9-B687-46C5-A6C7-E5B721BF354DQ41621925-988706FE-4A86-4546-AD6C-2617C8A298D6Q47301858-B65306A8-ABBC-47ED-9EA4-B15DFCC72B6FQ48104933-60C74050-C37E-464B-B068-14146C7DAACBQ49875986-0D48BF7D-A31C-45BA-AADF-2A4B77A940A2Q52588859-23BA3FB5-D07E-43FB-9FBA-60226D35EE62
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhaled corticosteroids in lung diseases.
@en
type
label
Inhaled corticosteroids in lung diseases.
@en
prefLabel
Inhaled corticosteroids in lung diseases.
@en
P2860
P1476
Inhaled corticosteroids in lung diseases.
@en
P2093
H William Kelly
Michelle Harkins
P2860
P304
P356
10.1164/RCCM.201210-1853PP
P407
P577
2013-04-01T00:00:00Z